John Matthews

Trials

Studies that name John Matthews as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:09 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT06633757 · Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance

  ReCode Therapeutics · completed · Primary Ciliary Dyskinesia (PCD) · study chair
• Ph1
  NCT06600425 · A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults With PCD

  ReCode Therapeutics · completed · Primary Ciliary Dyskinesia · study chair
• Ph2
  NCT06237335 · A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

  ReCode Therapeutics · active not recruiting · Cystic Fibrosis · study chair
• Ph1
  NCT05737485 · Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects

  ReCode Therapeutics · completed · Primary Ciliary Dyskinesia · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.